Dennis Liang Fei

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Squamous Cell Carcinoma

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science signaling

StemSynergy Therapeutics (United States)

Dartmouth College (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

StemSynergy Therapeutics (United States) Mar 26 2018

United States

Principal senior scientist

Weill Cornell Medical College Jul 15 2015 - Mar 25 2018

United States

Postdoc :: Medicine

National Institutes of Health Apr 15 2012 - Jul 14 2016

United States

Postdoc :: NHGRI

University of Miami School of Medicine Jun 01 2011 - Apr 14 2012

United States

Research Associate :: Molecular Oncology Program, Surgery

Education History

Dartmouth College Jun 01 2005 - Jun 01 2011

United States

PHD

Fudan University Sep 01 2000 - Jun 30 2004

China

BSC :: Biological Sciences

Publications

Long He, Dennis Liang Fei, Michal J Nagiec, Anders P Mutvei, Andreas Lamprakis, Bo Yeon Kim, John Blenis
Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin. Proceedings of the National Academy of Sciences of the United States of America 116 (39) (2019)
Dennis Liang Fei, Tao Zhen, Benjamin Durham, John Ferrarone, Tuo Zhang, Lisa Garrett, Akihide Yoshimi, Omar Abdel-Wahab, Robert K Bradley, Paul Liu, Harold Varmus
Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1. Proceedings of the National Academy of Sciences of the United States of America 115 (44) (2018)
Bin Li, Darren Orton, Leif R Neitzel, Luisana Astudillo, Chen Shen, Jun Long, Xi Chen, Kellye C Kirkbride, Thomas Doundoulakis, Marcy L Guerra, Julia Zaias, Dennis Liang Fei, Jezabel Rodriguez-Blanco, Curtis Thorne, Zhiqiang Wang, Ke Jin, Dao M Nguyen, Laurence R Sands, Floriano Marchetti, Maria T Abreu, Melanie H Cobb, Anthony J Capobianco, Ethan Lee, David J Robbins
Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors. Science signaling 10 (485) (2017)